INTERWEST PARTNERS X LP 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-10 1:00 pm Sale | 2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP | INTERWEST PARTNERS X LP | 1,714,540 3.800% | -1,535,004 (-47.24%) | Filing |
| 2022-02-14 06:51 am Sale | 2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP | INTERWEST PARTNERS X LP | 3,249,544 7.200% | -3,220,367 (-49.77%) | Filing |
| 2021-02-12 06:07 am Purchase | 2010-02-28 | 13G | PMV Pharmaceuticals, Inc. PMVP | INTERWEST PARTNERS X LP | 6,469,911 14.500% | 6,469,911 (New Position) | Filing |